Frank Konings

1.1k total citations
4 papers, 177 citations indexed

About

Frank Konings is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Frank Konings has authored 4 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmacology, 1 paper in Organic Chemistry and 1 paper in Molecular Biology. Recurrent topics in Frank Konings's work include Cholinesterase and Neurodegenerative Diseases (2 papers), Cardiac electrophysiology and arrhythmias (1 paper) and Dementia and Cognitive Impairment Research (1 paper). Frank Konings is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (2 papers), Cardiac electrophysiology and arrhythmias (1 paper) and Dementia and Cognitive Impairment Research (1 paper). Frank Konings collaborates with scholars based in China, Belgium and United States. Frank Konings's co-authors include Wim Parys, Sean Lilienfeld, Hugo Geerts, Jeroen Aerssens, Peter Raeymaekers, Martin Armstrong, Peter Verhasselt, Walter Luyten, Aimée Paulussen and Jan Hendrickx and has published in prestigious journals such as Neurobiology of Aging, Human Mutation and Dementia and Geriatric Cognitive Disorders.

In The Last Decade

Frank Konings

4 papers receiving 166 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Konings China	4	66	52	45	44	40	4	177
Lana Ganoci Croatia	10	77 1.2×	40 0.8×	70 1.6×	39 0.9×	37 0.9×	31	260
Bhaskar Rege United States	11	35 0.5×	56 1.1×	34 0.8×	40 0.9×	75 1.9×	31	325
Tamara Božina Croatia	12	75 1.1×	30 0.6×	65 1.4×	57 1.3×	67 1.7×	34	312
Yuichiro Kayano Japan	10	57 0.9×	161 3.1×	52 1.2×	32 0.7×	16 0.4×	31	388
Stefan Freudenthaler Germany	10	69 1.0×	29 0.6×	45 1.0×	49 1.1×	36 0.9×	15	308
Christiane Tillmann Germany	11	31 0.5×	51 1.0×	47 1.0×	40 0.9×	45 1.1×	11	362
Şükrü Aynacıoğlu Türkiye	7	184 2.8×	74 1.4×	98 2.2×	46 1.0×	36 0.9×	12	338
Masako Asoh Japan	9	166 2.5×	40 0.8×	92 2.0×	60 1.4×	43 1.1×	16	373
Tonya Quinlan United States	12	49 0.7×	120 2.3×	31 0.7×	57 1.3×	183 4.6×	16	387
Kristina Ryzhikova Russia	11	126 1.9×	64 1.2×	25 0.6×	26 0.6×	45 1.1×	45	318

Countries citing papers authored by Frank Konings

Since Specialization

Citations

This map shows the geographic impact of Frank Konings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Konings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Konings more than expected).

Fields of papers citing papers by Frank Konings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Konings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Konings. The network helps show where Frank Konings may publish in the future.

Co-authorship network of co-authors of Frank Konings

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Konings. A scholar is included among the top collaborators of Frank Konings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Konings. Frank Konings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Aerssens, Jeroen, Peter Raeymaekers, Sean Lilienfeld, et al.. (2001). <i>APOE</i> Genotype: No Influence on Galantamine Treatment Efficacy Nor on Rate of Decline in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 12(2). 69–77. 76 indexed citations

2.

Pangalos, Menelas N., Peter Verhasselt, Roger Marrannes, et al.. (2000). Analysis of the humanKCNH2(HERG) gene: Identification and characterization of a novel mutation Y667X associated with long QT syndrome and a non-pathological 9 bp insertion. Human Mutation. 15(5). 483–483. 21 indexed citations

3.

Paulussen, Aimée, Karel Lavrijsen, Hilde Bohets, et al.. (2000). Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans.. Pharmacogenetics. 10(5). 415–424. 74 indexed citations

4.

Aerssens, Jeroen, Sean Lilienfeld, Peter Raeymaekers, et al.. (2000). ApoE genotype: No influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease. Neurobiology of Aging. 21. 177–177. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact